NYHA classification for decision‐making in heart failure: Time to reassess?

European Journal of Heart FailureEarly View Viewpoint NYHA classification for decision-making in heart failure: Time to reassess? André Zimerman, André Zimerman Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Cardiovascular Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USASearch for more papers by this authorAnderson D. da Silveira, Anderson D. da Silveira Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Cardiovascular Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, BrazilSearch for more papers by this authorScott D. Solomon, Scott D. Solomon Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USASearch for more papers by this authorLuis E. Rohde, Corresponding Author Luis E. Rohde [email protected] orcid.org/0000-0002-6557-393X Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Cardiovascular Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil Corresponding author. Cardiovascular Division, Hospital de Clinicas de Porto Alegre, Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Porto Alegre RSW 90035-003, Brazil. Tel: + 55 51 33598342, Email: [email protected]Search for more papers by this author André Zimerman, André Zimerman Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Cardiovascular Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USASearch for more papers by this authorAnderson D. da Silveira, Anderson D. da Silveira Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Cardiovascular Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, BrazilSearch for more papers by this authorScott D. Solomon, Scott D. Solomon Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USASearch for more papers by this authorLuis E. Rohde, Corresponding Author Luis E. Rohde [email protected] orcid.org/0000-0002-6557-393X Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Cardiovascular Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil Corresponding author. Cardiovascular Division, Hospital de Clinicas de Porto Alegre, Post-Graduate Program in Cardiology and Cardiovascular Sciences, Medical School, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Porto Alegre RSW 90035-003, Brazil. Tel: + 55 51 33598342, Email: [email protected]Search for more papers by this author First published: 01 June 2023 https://doi.org/10.1002/ejhf.2923Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1White PD, Myers MM. The classification of cardiac diagnosis. JAMA 1921; 77: 1414– 1415. https://doi.org/10.1001/jama.1921.02630440034013 2Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J 2002; 23: 1861– 1866. https://doi.org/10.1053/euhj.2002.3282 3Bettencourt P, Ferreira A, Dias P, Pimenta J, Friões F, Martins L, et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail 2000; 6: 306– 313. https://doi.org/10.1054/jcaf.2000.20558 4Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Ferreira JP, Zannad F, et al. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: A comparative analysis of three randomised controlled trials. Lancet 2020; 396: 121– 128. https://doi.org/10.1016/S0140-6736(20)30748-0 5Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e876– e894. https://doi.org/10.1161/CIR.0000000000001062 6 CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429– 1435. https://doi.org/10.1056/NEJM198706043162301 7DeVore AD, Mi X, Thomas L, Sharma PP, Albert NM, Butler J, et al. Characteristics and treatments of patients enrolled in the CHAMP-HF registry compared with patients enrolled in the PARADIGM-HF trial. J Am Heart Assoc 2018; 7:e009237. https://doi.org/10.1161/JAHA.118.009237 8Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 2017; 19: 1624– 1634. https://doi.org/10.1002/ejhf.945 9Linssen GCM, Veenis JF, Brunner-La Rocca HP, van Pol PEJ, Engelen DJM, van Tooren RM, et al., CHECK-HF Investigators. Differences in guideline-recommended heart failure medication between Dutch heart failure clinics: An analysis of the CHECK-HF registry. Neth Heart J 2020; 28: 334– 344. https://doi.org/10.1007/s12471-020-01421-1 10Sjöland H, Silverdal J, Bollano E, Pivodic A, Dahlström U, Fu M. Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003–2015. BMC Cardiovasc Disord 2021; 21: 307. https://doi.org/10.1186/s12872-021-02124-0 11Goldberg LR, Jessup M. Stage B heart failure: Management of asymptomatic left ventricular systolic dysfunction. Circulation 2006; 113: 2851– 2860. https://doi.org/10.1161/CIRCULATIONAHA.105.600437 12 SOLVD Investigators; Yusuf S, Pitt B, Davis CE, Hood WB Jr, Cohn JN. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685– 691. https://doi.org/10.1056/NEJM199209033271003 13Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study. Lancet 2003; 361: 1843– 1848. https://doi.org/10.1016/S0140-6736(03)13501-5 14McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al., PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371: 993– 1004. https://doi.org/10.1056/NEJMoa1409077 15Raphael C, Briscoe C, Davies J, Whinnett ZI, Manisty C, Sutton R, et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007; 93: 476– 482. https://doi.org/10.1136/hrt.2006.089656 16Caraballo C, Desai NR, Mulder H, Alhanti B, Wilson FP, Fiuzat M, et al. Clinical implications of the New York Heart Association classification. J Am Heart Assoc 2019; 8:e014240. https://doi.org/10.1161/JAHA.119.014240 17Blacher M, Zimerman A, Engster PHB, Grespan E, Polanczyk CA, Rover MM, et al. Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II. Heart 2020; 107: 1487– 1492. https://doi.org/10.1136/heartjnl-2020-317984 18Zimerman A, da Silveira AD, Borges MS, Engster PHB, Schaan TU, de Souza GC, et al. Functional assessment based on cardiopulmonary exercise testing in mild heart failure: A multicentre study. ESC Heart Fail 2023; 10: 1689– 1697. https://doi.org/10.1002/ehf2.14287 19Rohde LE, Zimerman A, Vaduganathan M, Claggett BL, Packer M, Desai AS, et al. Associations between New York Heart Association classification, objective measures, and long-term prognosis in mild heart failure: A secondary analysis of the PARADIGM-HF trial. JAMA Cardiol 2023; 8: 150– 158. https://doi.org/10.1001/jamacardio.2022.4427 20Greene SJ, Butler J, Spertus JA, Hellkamp AS, Vaduganathan M, DeVore AD, et al. Comparison of New York Heart Association class and patient-reported outcomes for heart failure with reduced ejection fraction. JAMA Cardiol 2021; 6: 522– 531. https://doi.org/10.1001/jamacardio.2021.0372 21Cosiano MF, Vista A, Sun JL, Alhanti B, Harrington J, Butler J, et al. Comparing New York Heart Association class and patient-reported outcomes among patients hospitalized for heart failure. Circ Heart Fail 2023; 16:e010107. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010107 22Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res 2022; 118: 3272– 3287. https://doi.org/10.1093/cvr/cvab077 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation